Objectives-The APOE ε4 allele and a history of depression are each separate risk factors for cognitive decline (CD). However, little research has investigated whether a history of depression influences the relationship between APOE ε4 and CD. The present study examined whether depressive symptoms had greater influence on subsequent CD among participants with APOE ε4 than those without the allele.
Design-Prospective six year longitudinal study.
Setting-Community in-home interviews.
Participants-A biracial sample of community dwelling older adults (N=1992) from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE).Measurements-Data were drawn from Waves 1 and 3 of the EPESE, which were conducted 6 years apart. Cognitive functioning and depressive symptoms were assessed at both waves, and APOE genotyping was completed during the Wave 3 assessment.Results-Regression analyses revealed that depressive symptoms and the APOE ε4 allele independently predicted CD. Importantly, the influence of depressive symptoms on CD was greater for individuals with the APOE ε4 allele compared to those without the allele.Conclusion-Depressive symptoms and the APOE ε4 allele are independent contributors to CD. Moreover, the influence of depressive symptoms on CD is greater among individuals with the APOE ε4 allele. Depression and the APOE ε4 allele may act together in disrupting neurological functioning, which may in turn lower an individual's cognitive reserve capacity. Given the efficacious treatments currently available for depression, future research should investigate the extent to which interventions for depression may reduce the risk for subsequent CD.
Keywords
APOE; depressive symptoms; cognitive declineCognitive decline (CD) is a significantly increasing problem as individuals age. Mild cognitive impairment affects between 22% and 56% of older adults [1,2], and the prevalence of dementia
NIH Public Access
Author ManuscriptAm J Geriatr Psychiatry. Author manuscript; available in PMC 2010 February 1.
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript in individuals 65 years and older is approximately 6 to 10%. Further, the prevalence of dementia climbs above 30% among individuals over age 85 [3]. Given the pervasiveness of cognitive impairment in our society, further investigation of factors that influence the onset and course of CD is merited. Identifying such factors may lead to greater insight into ways to prevent or slow the progression of CD. Two variables that have each been individually identified as placing a person at an increased risk for CD are the apolipoproteinE ε4 allele (APOE ε4) and a history of depression or depressive symptoms. APOE ε4 is the most widely recognized genetic risk factor for Alzheimer's disease (AD) [4][5][6]. Nevertheless, other environmental or biological factors are also likely operating to influence CD. In particular, there is growing evidence that a history of depression may increase the risk for CD [7]. Although many studies have exa...